Similar risks of complications and reoperation rates in proximal femur megaprostheses for oncological and non-oncological indications
International Orthopaedics · 2025
DOI: 10.1007/s00264-025-06408-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Orthopaedics, 2025. Verfasst von Guillaume Tran und 6 weiteren Autor:innen. Beteiligte Einrichtung: CHU de Nantes, Nantes University, CHU Nantes, Clinique Chirurgicale Orthopédique et Traumatologique, 1 Place Alexis Ricordeau, 44000, Nantes, France.…. Hauptthemen laut MEDLINE: Reoperation, Femur, Postoperative Complications, Femoral Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: Proximal femur megaprostheses (PFMPs) are used to manage large bone defects in both non-oncological indications (NOI) and oncological indications (OI). However, little is known about the comparative risks of reoperation and functional outcomes between these groups. This study aimed to evaluate the cumulative incidences of reoperation and functional results of PFMPs between NOI and OI. METHODS: This retrospective, monocentric cohort study included 109 implants between 2005 and 2020 (NOI, n = 42; OI, n = 67). Competing risk analysis was used to estimate and compare cumulative incidence of reoperation and complications, with death as a competing event. The Musculoskeletal Tumour Society Score (MSTS) was retrospectively assessed to compare functional outcomes. RESULTS: The estimated cumulative incidence of reoperation at ten years did not statistically differ: 33.5% for NOI vs. 32.7% for OI (HR = 0.90, 95% CI (0.42-0.95), p = 0.791). The estimated cumulative incidence of complications at ten years did not statistically differ (HR = 1.50, 95%CI (0.80-2.80), p = 0.204). The MSTS score at ten years was significantly higher in the OI group (78.2% ± 19.5) compared to the NOI group (48.3% ± 10.9) (p = 0.012). CONCLUSION: PFMPs for NOI demonstrate a comparable risk of reoperation to OI, but with lower long-term functional outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- CHU de Nantes, Nantes University, CHU Nantes, Clinique Chirurgicale Orthopédique et Traumatologique, 1 Place Alexis Ricordeau, 44000, Nantes, France. tran.guigui@gmail.com.
- CRCI2NA (Centre de Recherche en Cancérologie et Immunologie Nantes-Angers), INSERM UMR 1307, CNRS UMR 6075-Team 9 CHILD (CHromatin and Transcriptional Deregulation in Pediatric Bone Sarcoma), Nantes Université, Nantes,…
- CHU de Nantes, Nantes University, CHU Nantes, Clinique Chirurgicale Orthopédique et Traumatologique, 1 Place Alexis Ricordeau, 44000, Nantes, France.
- INSERM, UMRS 1229, Regenerative Medicine and Skeleton (RMeS), ONIRIS, Nantes, France.
- Plateforme de Méthodologie et Biostatistique, CHU de Nantes, Nantes, France.
- Département de Chirurgie, Centre Léon Bérard, Lyon, France.
ORCID-Profile: Guillaume Tran
Zitieren
APA
Tran, G., Waast, D., Nich, C., Pere, M., Berchoud, J., Gouin, F., & Crenn, V. (2025). Similar risks of complications and reoperation rates in proximal femur megaprostheses for oncological and non-oncological indications. International Orthopaedics. https://doi.org/10.1007/s00264-025-06408-4
Vancouver
Tran G, Waast D, Nich C, Pere M, Berchoud J, Gouin F, et al. Similar risks of complications and reoperation rates in proximal femur megaprostheses for oncological and non-oncological indications. International Orthopaedics. 2025. doi:10.1007/s00264-025-06408-4
BibTeX
@article{Tran2025,
author = {Tran, Guillaume and Waast, Denis and Nich, Christophe and Pere, Morgane and Berchoud, Juliane and Gouin, Francois and Crenn, Vincent},
title = {Similar risks of complications and reoperation rates in proximal femur megaprostheses for oncological and non-oncological indications},
journal = {International Orthopaedics},
year = {2025},
doi = {10.1007/s00264-025-06408-4}
}
EUVIMED